PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Julie Stakiw, MD, FRCPC - Clinical Conundrums in CLL: When to Use Continuous Versus Fixed-Duration Treatment
Visit https://www.peervoice.com/BAC860 to view the entire programme with slides. After completing “Julie Stakiw, MD, FRCPC - Clinical Conundrums in CLL: When to Use Continuous Versus Fixed-Duration Treatment”, participants will be able to: Evaluate long-term data with novel agents used for continuous or fixed-duration treatment (FDT) regimens in chronic lymphocytic leukemia (CLL); Assess patient risk level, incorporating cytogenetics, age, and other key considerations; and Discuss CLL treatment approach based on patient risk level.